Deals
Allergan Takeover Closer After Court Allows Ackman’s Vote
This article is for subscribers only.
Allergan Inc. moved closer to a takeover -- hostile or friendly -- after a judge rebuffed the Botox maker’s bid to prevent Bill Ackman, its largest shareholder, from trying to oust directors opposed to an acquisition by Valeant Pharmaceuticals International Inc.
Allergan shares rose to a 52-week high yesterday following the ruling by a federal judge in Santa Ana, California.